Synthesis of L-Dopa (3,4-dihydroxyphenyl-L-alanine). 1971

H Nakamoto, and M Aburatani, and M Inagaki

UI MeSH Term Description Entries
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine

Related Publications

H Nakamoto, and M Aburatani, and M Inagaki
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
H Nakamoto, and M Aburatani, and M Inagaki
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
H Nakamoto, and M Aburatani, and M Inagaki
May 1975, Angewandte Chemie (International ed. in English),
H Nakamoto, and M Aburatani, and M Inagaki
January 1971, Acta chemica Scandinavica,
H Nakamoto, and M Aburatani, and M Inagaki
July 2002, Biochemical and biophysical research communications,
H Nakamoto, and M Aburatani, and M Inagaki
January 1972, Chemische Berichte,
H Nakamoto, and M Aburatani, and M Inagaki
January 1998, Biotechnology and bioengineering,
H Nakamoto, and M Aburatani, and M Inagaki
January 1971, Journal of the Chemical Society. Perkin transactions 1,
H Nakamoto, and M Aburatani, and M Inagaki
October 2005, Biotechnology and applied biochemistry,
H Nakamoto, and M Aburatani, and M Inagaki
September 1971, Pharmaceutisch weekblad,
Copied contents to your clipboard!